For millions suffering from chronic acid reflux, finding lasting relief can be difficult. A new clinical trial will investigate whether genotype-guided treatment can improve results.
The study, led by UF Health Jacksonville and the University of Florida College of Pharmacy, will be the first to examine whether genotype-guided dosing of proton pump inhibitor medications, or PPIs, can improve treatment outcomes for erosive esophagitis. Researchers plan to enroll 200 patients over the next year.
Read more about UF Health Jacksonville Trial Explores DNA-Guided Treatment for Acid Reflux.
